Renaissance BioScience Corp adds Senior Executive Expertise to Push Commercialization of its RNA Production and Oral Delivery Platform Technology

Renaissance BioScience Corp., a leader in bioengineering for the global agriculture and food industries, announced that it has retained the services of S. Brad Griffith to assist Renaissance in commercializing its RNA production and oral delivery platform technology applications for agricultural crop protection, non-agriculture biocontrol and animal health.
 Mr. Griffith has more than 30 years’ experience in the agriculture industry and life sciences, much of it at a senior executive level, including leading the global commercial BioAg Alliance, a joint venture of Monsanto and Novozymes representing the largest microbials business in the world at that time. He was most recently Chief Commercial Officer at Compass Minerals, an Overland Park, KS-based NYSE public company.
 Maurice Boucher, Executive Chair at Renaissance BioScience Corp.:
 

"Brad’s industry knowledge, strategic vision, and operational implementation capabilities are a perfect fit to maximize the extensive global commercial opportunities for valuable product creation in agricultural crop protection, animal health and biocontrol that the Renaissance RNA platform technology has application for."

"Renaissance’s technology addresses the need for environmentally friendly agriculture technologies that are effective and affordable."

"With the help of experienced senior industry executives like Brad Griffith, we can make major contributions to the future of sustainable agriculture."

Brad Griffith:
 

"I am impressed by the innovation capabilities and IP of Renaissance BioScience and their potential to develop next-generation technologies that can help producers maximize economic returns more sustainably."

"I am excited to work with the Renaissance team to bring their technologies to industry. They are very open to partnerships and co-creation."